Jaundice following warfarin therapy.

Jaundice following warfarin therapy.

A case of intrahepatic cholestatic jaundice following warfarin therapy is described. The patient made a complete recovery on withdrawal on the drug.

Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.

Ticlopidine, an adenosine diphosphate receptor blocker, is widely used to prevent subacute stent thrombosis after percutaneous coronary intervention. Along with neutropenia and thrombotic thrombocytopenic purpura, cholestatic hepatitis is one of the most serious potential side-effects of ticlopidine therapy. Four patients with prolonged jaundice after ticlopidine therapy, including one fatal ca...

Cholestatic jaundice following carbimazole therapy in an elderly thyrotoxic patient.

Jaundice following acetarsol pessaries.

Miss X, a machinist, aged 19 years, consulted her doctor on 8. 11. 50 because she had a whitish vaginal discharge. Acetarsol pessaries were prescribed, and she was told to insert one pessary into the vagina daily. On 11. 11. 50 she complained of shivering, fever, oedema of the eyelids, lips, and face, and chemosis. There was a morbilliform eruption on the trunk, forearms, and arms. On 14. 11. 5...

Jaundice from diabetes therapy.

In January 2013, a 41-year-old man presented for follow-up to our diabetes unit with jaundice, fatigue, dark urine, and stool discoloration. Four weeks earlier, he had suffered a sudden sensorineural hearing loss and was treated with a prednisolone taper scheme starting with 250 mg q.i.d. in addition to a-lipoic acid. Fasting hyperglycemia (274 mg/dL) was detected after initiation of the therap...